Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 47

Cited In for PubMed (Select 11176272)

1.

Factors that influence adherence to antiretroviral treatment in an urban population, Jakarta, Indonesia.

Weaver ER, Pane M, Wandra T, Windiyaningsih C, Herlina, Samaan G.

PLoS One. 2014 Sep 17;9(9):e107543. doi: 10.1371/journal.pone.0107543. eCollection 2014.

2.

Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis.

Langebeek N, Gisolf EH, Reiss P, Vervoort SC, Hafsteinsdóttir TB, Richter C, Sprangers MA, Nieuwkerk PT.

BMC Med. 2014 Aug 21;12:142. doi: 10.1186/PREACCEPT-1453408941291432.

3.

A Mediation Model to Explain HIV Antiretroviral Adherence Among Gay and Bisexual Men.

Halkitis PN, Palamar J.

J Gay Lesbian Soc Serv. 2008;19(1):35-55.

4.

Markov Chain Modelling Analysis of HIV/AIDS Progression: A Race-based Forecast in the United States.

Lee S, Ko J, Tan X, Patel I, Balkrishnan R, Chang J.

Indian J Pharm Sci. 2014 Mar;76(2):107-15.

5.
6.

Prevalence and determinants of adherence to HAART amongst PLHIV in a tertiary health facility in south-south Nigeria.

Oku AO, Owoaje ET, Ige OK, Oyo-Ita A.

BMC Infect Dis. 2013 Aug 30;13:401. doi: 10.1186/1471-2334-13-401.

7.

Retention in care is more strongly associated with viral suppression in HIV-infected patients with lower versus higher CD4 counts.

Yehia BR, French B, Fleishman JA, Metlay JP, Berry SA, Korthuis PT, Agwu AL, Gebo KA; HIV Research Network.

J Acquir Immune Defic Syndr. 2014 Mar 1;65(3):333-9. doi: 10.1097/QAI.0000000000000023.

8.

Racial differences in response to antiretroviral therapy for HIV infection: an AIDS clinical trials group (ACTG) study analysis.

Ribaudo HJ, Smith KY, Robbins GK, Flexner C, Haubrich R, Chen Y, Fischl MA, Schackman BR, Riddler SA, Gulick RM.

Clin Infect Dis. 2013 Dec;57(11):1607-17. doi: 10.1093/cid/cit595. Epub 2013 Sep 17.

9.

Aging, antiretrovirals, and adherence: a meta analysis of adherence among older HIV-infected individuals.

Ghidei L, Simone MJ, Salow MJ, Zimmerman KM, Paquin AM, Skarf LM, Kostas TR, Rudolph JL.

Drugs Aging. 2013 Oct;30(10):809-19. doi: 10.1007/s40266-013-0107-7. Review.

10.

What are validated self-report adherence scales really measuring?: a systematic review.

Nguyen TM, La Caze A, Cottrell N.

Br J Clin Pharmacol. 2014 Mar;77(3):427-45. doi: 10.1111/bcp.12194. Review.

11.

A pandemic of the poor: social disadvantage and the U.S. HIV epidemic.

Pellowski JA, Kalichman SC, Matthews KA, Adler N.

Am Psychol. 2013 May-Jun;68(4):197-209. doi: 10.1037/a0032694.

12.

Adherence to Antiretroviral Therapy Among People Living with HIV.

Achappa B, Madi D, Bhaskaran U, Ramapuram JT, Rao S, Mahalingam S.

N Am J Med Sci. 2013 Mar;5(3):220-3. doi: 10.4103/1947-2714.109196.

13.

Barriers to and facilitators of antiretroviral therapy adherence in Nepal: a qualitative study.

Wasti SP, Simkhada P, Randall J, Freeman JV, van Teijlingen E.

J Health Popul Nutr. 2012 Dec;30(4):410-9.

14.

Use of and Adherence to Antiretroviral Therapy in a Large U.S. Sample of HIV-infected Adults in Care, 2007-2008.

Beer L, Heffelfinger J, Frazier E, Mattson C, Roter B, Barash E, Buskin S, Rime T, Valverde E.

Open AIDS J. 2012;6:213-23. doi: 10.2174/1874613601206010213. Epub 2012 Sep 7.

15.

Racial/Ethnic disparities in ART adherence in the United States: findings from the MACH14 study.

Simoni JM, Huh D, Wilson IB, Shen J, Goggin K, Reynolds NR, Remien RH, Rosen MI, Bangsberg DR, Liu H.

J Acquir Immune Defic Syndr. 2012 Aug 15;60(5):466-72.

16.

Factors influencing adherence to antiretroviral treatment in Nepal: a mixed-methods study.

Wasti SP, Simkhada P, Randall J, Freeman JV, van Teijlingen E.

PLoS One. 2012;7(5):e35547. doi: 10.1371/journal.pone.0035547. Epub 2012 May 1.

17.

Association between race, depression, and antiretroviral therapy adherence in a low-income population with HIV infection.

Kong MC, Nahata MC, Lacombe VA, Seiber EE, Balkrishnan R.

J Gen Intern Med. 2012 Sep;27(9):1159-64. doi: 10.1007/s11606-012-2043-3. Epub 2012 Apr 17.

18.

Clinical significance of hyperbilirubinemia among HIV-1-infected patients treated with atazanavir/ritonavir through 96 weeks in the CASTLE study.

McDonald C, Uy J, Hu W, Wirtz V, Juethner S, Butcher D, McGrath D, Farajallah A, Moyle G.

AIDS Patient Care STDS. 2012 May;26(5):259-64. doi: 10.1089/apc.2011.0092. Epub 2012 Mar 9.

19.

Provider-patient adherence dialogue in HIV care: results of a multisite study.

Laws MB, Beach MC, Lee Y, Rogers WH, Saha S, Korthuis PT, Sharp V, Wilson IB.

AIDS Behav. 2013 Jan;17(1):148-59.

20.

Adherence to highly active antiretroviral treatment in HIV-infected Rwandan women.

Musiime S, Muhairwe F, Rutagengwa A, Mutimura E, Anastos K, Hoover DR, Qiuhu S, Munyazesa E, Emile I, Uwineza A, Cowan E.

PLoS One. 2011;6(11):e27832. doi: 10.1371/journal.pone.0027832. Epub 2011 Nov 17.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk